Melatonine Bluefish (Melatonin)

Melatonin works by binding to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus, the central regulator of circadian rhythms. This mimics the natural rise in melatonin at night, signaling the body that it is time to sleep and helping to synchronize the sleep‑wake cycle.

The appropriate dose of melatonin is individualized and should be determined by a qualified healthcare professional based on the patient’s age, condition and response. Prescribers set the specific amount and timing that best fits the therapeutic need.

Safety data for melatonin use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting melatonin therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Melatonin differs from prescription hypnotics in that it is a hormone that restores natural circadian signalling rather than directly depressing the central nervous system. It generally has a milder side‑effect profile and is available over the counter, whereas many alternative sleep medications require a prescription and may carry higher risks of dependence.

Melatonine Bluefish should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The product is taken orally, typically with a glass of water. It is usually recommended to ingest the dose shortly before the intended bedtime, following the timing instructions provided by the prescribing clinician.

While rare, serious adverse events can include severe allergic reactions such as rash, swelling or difficulty breathing, as well as significant mood changes like depression or suicidal thoughts. Any sudden or severe symptoms should prompt immediate medical evaluation.

Individuals with known hypersensitivity to melatonin, those taking certain interacting medications (e.g., strong CYP1A2 inhibitors), and patients with uncontrolled severe liver disease should avoid melatonin unless directed otherwise by a healthcare professional.